Robert Feil

University of Tübingen

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Tilman Schäffer

Faculty/Professor

Eberhard Karls Universität Tübingen

GERMANY

View details

Gerald Reischl

Head of Radiopharmacy

University Hospital of Tuebingen

GERMANY

View details

Prof. Dr. Tassula Proikas-Cezanne

Professor for Cell Biology and Molecular Biology

Eberhard Karls Universität Tübingen

GERMANY

View details

Susanne Feil

University of Tübingen

GERMANY

View details

Oliver Borst

Professor of Cardiology, Consultant

Universitätsklinikum Tübingen

GERMANY

View details

Bernd Nürnberg

Professor (W3/C4) of Pharmacology and Toxicology; Department Head and Chairman

University of Tübingen

GERMANY

View details

Markus Bender

Professor for Cardiovascular Cell Biology

University Hospital Würzburg

GERMANY

View details

Zouhair Aherrahrou

University of Lübeck

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Feil

Research Interests

Explore related searches

Contact this professor

Articles (21)

International symposium “The Different Facets of Guanine Nucleotide Signaling”

New biosensors and transgenic mice for multiplex cGMP imaging

Smooth Muscle Cell‐Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO‐cGMP Signaling

Pharmacological activation of NO-sensitive guanylyl cyclase ameliorates obesity-induced arterial stiffness.

Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis

Role of the NO-GC/cGMP signaling pathway in platelet biomechanics

Inhibition of Phosphodiesterase 10A Alleviates Pain-like Behavior in Mice.

Real-time imaging of cGMP signaling shows pronounced differences between glomerular endothelial cells and podocytes.

Targeting Cyclophilin A in the Cardiac Microenvironment Preserves Heart Function and Structure in Failing Hearts.

Carvedilol Activates a Myofilament Signaling Circuitry to Restore Cardiac Contractility in Heart Failure.

Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in Mice

Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in Mice

Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes

Protocol to visualize CD11c<sup>+</sup> cells in atherosclerosis using LacZ reporter mice.

A modular systems biological modelling framework studies cyclic nucleotide signaling in platelets.

Visualising and understanding cGMP signals in the cardiovascular system

Recent developments in cGMP research: From mechanisms to medicines and back.

The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.

Apolipoprotein E derived from CD11c<sup>+</sup> cells ameliorates atherosclerosis.

Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney.

Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.

Collaborators (8)

Tilman Schäffer

Gerald Reischl

Prof. Dr. Tassula Proikas-Cezanne

Susanne Feil

Oliver Borst

Bernd Nürnberg

Markus Bender

Zouhair Aherrahrou

Make your next move.